Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

UK Medical Devices Agency (MDA) rates erythropoietin (EPO) kits

This article was originally published in Clinica

Executive Summary

ELISA and EIA erythropoietin tests have lower limits of detection but RIAs are easier to use, says a survey by the UK Medical Devices Agency (MDA). The agency evaluated six erythropoietin (EPO) kits: RIAs from Incstar, Ramco Laboratories and Diagnostic Systems Laboratories; an EIA from bioMerieux; and ELISAs by IBL and Medac. Incstar's EPO-Trac RIA was used as the reference test. Nichols Institute's CLIA kit was initially included, but was discounted when the company withdrew it from the market. A new version was launched in May 1995.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT087425

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel